1. Home
  2. DNUT vs ZVRA Comparison

DNUT vs ZVRA Comparison

Compare DNUT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.56

Market Cap

577.8M

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$11.99

Market Cap

562.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
ZVRA
Founded
1937
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
577.8M
562.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
DNUT
ZVRA
Price
$3.56
$11.99
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$4.15
$23.00
AVG Volume (30 Days)
3.2M
1.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.74
Revenue
$1,522,616,000.00
$106,470,000.00
Revenue This Year
$0.55
$37.27
Revenue Next Year
$3.59
$53.42
P/E Ratio
N/A
$16.05
Revenue Growth
N/A
350.91
52 Week Low
$2.88
$7.16
52 Week High
$5.11
$15.04

Technical Indicators

Market Signals
Indicator
DNUT
ZVRA
Relative Strength Index (RSI) 58.79 55.08
Support Level $3.12 $8.15
Resistance Level $3.74 $12.19
Average True Range (ATR) 0.19 0.44
MACD 0.05 0.15
Stochastic Oscillator 77.42 76.16

Price Performance

Historical Comparison
DNUT
ZVRA

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: